ipriflavone has been researched along with Lung Neoplasms in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caltagirone, S | 1 |
| Ranelletti, FO | 1 |
| Rinelli, A | 1 |
| Maggiano, N | 1 |
| Colasante, A | 1 |
| Musiani, P | 1 |
| Aiello, FB | 1 |
| Piantelli, M | 1 |
1 other study available for ipriflavone and Lung Neoplasms
| Article | Year |
|---|---|
Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer.
Topics: Aged; Analgesics; Animals; Binding, Competitive; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell | 1997 |